Staphylococcus lugdunensis Endocarditis Causing Secondary Splenic Abscess: A Potentially Lethal Complication

Infective endocarditis is a potentially life-threatening condition caused by a bacterial infection of the heart valves. The incidence of splenic abscess associated with infective endocarditis varies between 1-10% of cases, and its presence may indicate a severe form of the disease. We present a 24-y...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 16; no. 1; p. e52948
Main Authors Raj, Kishen, Loo, Guo Hou, Shamugam, Navindra, Leong, Chee Loon
Format Journal Article
LanguageEnglish
Published United States Cureus Inc 25.01.2024
Subjects
Abdomen
Abscesses
Antibiotics
Cardiology
Embolization
Endocarditis
Infectious diseases
Laparotomy
Medical imaging
Morbidity
Pathogens
Patients
Spleen
Staphylococcus infections
Surgeons
Surgery
Ultrasonic imaging
Vegetation
staphylococcus lugdunensis
infective endocarditis
splenectomy
targeted antibiotics
splenic abscess
Online AccessGet full text

Cover

More Information
Summary:Infective endocarditis is a potentially life-threatening condition caused by a bacterial infection of the heart valves. The incidence of splenic abscess associated with infective endocarditis varies between 1-10% of cases, and its presence may indicate a severe form of the disease. We present a 24-year-old man diagnosed with infective endocarditis who was found to have a splenic abscess upon further evaluation. The patient was initially managed conservatively with targeted antibiotics, but after unsuccessful percutaneous drainage, a splenectomy was performed. The patient underwent mitral valve replacement surgery and made a good recovery. The patient's case highlights the importance of considering a secondary abscess in the management of infective endocarditis. This complication can easily be missed and cause significant morbidity. This case underscores the importance of early diagnosis and effective collaboration between various healthcare professionals to achieve the best possible outcome for patients with infective endocarditis and its associated complications.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.52948